The U.S. maternal mortality rate is accelerating at an alarming rate, reports a new study from Northwestern Medicine.
GSK’s RSV vaccine Arexvy shows long-term protection in Phase 3 trial
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS